Ratings 3M India Limited NSE India S.E.

Equities

3MINDIA

INE470A01017

Market Closed - NSE India S.E. 07:43:47 2024-05-03 am EDT 5-day change 1st Jan Change
29,697 INR -0.12% Intraday chart for 3M India Limited -0.90% -20.40%

Strengths

  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 59.14 times its estimated earnings per share for the ongoing year.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

Ratings chart - Surperformance

Sector: Consumer Goods Conglomerates

1st Jan change Capi. Investor Rating ESG Refinitiv
-20.40% 4B -
+11.13% 865B
D+
+0.03% 239B -
C
+28.62% 180B
B
-6.63% 128B
B-
+42.13% 87.6B
B+
-11.13% 53.76B
C+
+41.87% 38.73B
A
-27.13% 37.3B - -
+71.52% 31.07B
B-
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality